Probiotics mediated gut microbiota diversity shifts are associated with reduction in histopathology and shedding of Lawsonia intracellularis.
Lawsonia intracellularis
Metagenomics
Microbial community
Pigs
Probiotics
Vaccine
Journal
Animal microbiome
ISSN: 2524-4671
Titre abrégé: Anim Microbiome
Pays: England
ID NLM: 101759457
Informations de publication
Date de publication:
04 Mar 2021
04 Mar 2021
Historique:
received:
27
09
2020
accepted:
11
02
2021
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
6
3
2021
Statut:
epublish
Résumé
Clinical intervention during bacterial infections in farm animals such as pigs commonly includes the use of antimicrobials. With the rise of antimicrobial resistance and the attempts to reduce the use of antibiotics in food animals, effective alternatives are urgently needed to reduce or even remove pathogens and disease risks. Improving clinical outcomes and overall pig health by using probiotics appears attractive. However, reliable data sets on the efficacy of probiotics are scarce. The obligate intracellular bacterium Lawsonia intracellularis is widespread in pigs and associated with severe enteropathy, mainly in the ileum, commonly resulting in substantial reduction in weight gain. The impact of three in-feed probiotics and a commercial live L. intracellularis vaccine was compared in a pig challenge model. Probiotic treatment was associated with reduced L. intracellularis fecal shedding and reduced gut lesions. Here, the bacterial microbiota of the ileum of these pigs was characterized with 16S rRNA gene sequencing and was subsequently analyzed with bioinformatics tools. The greatest microbial richness was observed in the probiotic treated group T03-LAW, which accounted for 87% of richness observed in the study. Treatment had a significant impact on both the microbiota structure and taxonomic profile in the ileum, explaining between 26 and 36% of the structural variation, with the strongest association in the T03-LAW group. Overall, the largest changes were observed for the pigs treated with in-feed Bacillus pumilus; the microbiota of these pigs had the greatest diversity and highest richness. We also observed depleted and enriched core microbiota amongst the groups; however, there was no correlation with clinical characteristics. The results suggest that an increased diversity of the ileal microbiota is associated with a reduction in shedding, i.e. a unit increase in Shannon diversity index resulted in 2.8 log reduction in shedding. Probiotic supplementation of a base feed ration increased ileum microbiota diversity leading to a mitigation of the effects of a pathogenic L. intracellularis challenge. An even and diverse microbiota community benefits pigs infected with L. intracellularis, however, investigations are needed to determine if this is also true for other pathogens. The study unambiguously demonstrates the usefulness of probiotic supplementation in reducing the impact of enteric pathogens and pathogen shedding rates in food animals without the use of antimicrobials.
Sections du résumé
BACKGROUND
BACKGROUND
Clinical intervention during bacterial infections in farm animals such as pigs commonly includes the use of antimicrobials. With the rise of antimicrobial resistance and the attempts to reduce the use of antibiotics in food animals, effective alternatives are urgently needed to reduce or even remove pathogens and disease risks. Improving clinical outcomes and overall pig health by using probiotics appears attractive. However, reliable data sets on the efficacy of probiotics are scarce. The obligate intracellular bacterium Lawsonia intracellularis is widespread in pigs and associated with severe enteropathy, mainly in the ileum, commonly resulting in substantial reduction in weight gain. The impact of three in-feed probiotics and a commercial live L. intracellularis vaccine was compared in a pig challenge model. Probiotic treatment was associated with reduced L. intracellularis fecal shedding and reduced gut lesions. Here, the bacterial microbiota of the ileum of these pigs was characterized with 16S rRNA gene sequencing and was subsequently analyzed with bioinformatics tools.
RESULTS
RESULTS
The greatest microbial richness was observed in the probiotic treated group T03-LAW, which accounted for 87% of richness observed in the study. Treatment had a significant impact on both the microbiota structure and taxonomic profile in the ileum, explaining between 26 and 36% of the structural variation, with the strongest association in the T03-LAW group. Overall, the largest changes were observed for the pigs treated with in-feed Bacillus pumilus; the microbiota of these pigs had the greatest diversity and highest richness. We also observed depleted and enriched core microbiota amongst the groups; however, there was no correlation with clinical characteristics. The results suggest that an increased diversity of the ileal microbiota is associated with a reduction in shedding, i.e. a unit increase in Shannon diversity index resulted in 2.8 log reduction in shedding.
CONCLUSIONS
CONCLUSIONS
Probiotic supplementation of a base feed ration increased ileum microbiota diversity leading to a mitigation of the effects of a pathogenic L. intracellularis challenge. An even and diverse microbiota community benefits pigs infected with L. intracellularis, however, investigations are needed to determine if this is also true for other pathogens. The study unambiguously demonstrates the usefulness of probiotic supplementation in reducing the impact of enteric pathogens and pathogen shedding rates in food animals without the use of antimicrobials.
Identifiants
pubmed: 33663618
doi: 10.1186/s42523-021-00084-6
pii: 10.1186/s42523-021-00084-6
pmc: PMC7931366
doi:
Types de publication
Journal Article
Langues
eng
Pagination
22Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/D/20002173
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/D/20002174
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P007767/1
Pays : United Kingdom
Organisme : College of Medicine and Veterinary Medicine, University of Edinburgh (GB)
ID : 1S3-RI.0919/20
Références
J Clin Microbiol. 2012 Mar;50(3):1070-2
pubmed: 22219308
Vet Microbiol. 2008 Apr 1;128(1-2):96-107
pubmed: 17996403
Can J Vet Res. 2006 Apr;70(2):155-9
pubmed: 16639950
Front Physiol. 2019 Mar 14;10:185
pubmed: 30923502
Antibiotics (Basel). 2018 Aug 15;7(3):
pubmed: 30111750
J Comp Pathol. 2000 Feb-Apr;122(2-3):77-100
pubmed: 10684678
J Am Vet Med Assoc. 2016 Apr 15;248(8):897-9
pubmed: 27031415
Porcine Health Manag. 2019 Dec 17;5:31
pubmed: 31890255
Equine Vet J. 2019 Sep;51(5):665-668
pubmed: 30629755
Vet Microbiol. 2003 May 19;93(2):159-66
pubmed: 12637004
Animals (Basel). 2019 Feb 28;9(3):
pubmed: 30823381
BMC Microbiol. 2019 Jan 31;19(1):27
pubmed: 30704407
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
Front Microbiol. 2019 Oct 15;10:2345
pubmed: 31681210
Parasitol Res. 2015 Aug;114(8):3069-73
pubmed: 25963884
J Theor Biol. 2004 Jun 21;228(4):523-37
pubmed: 15178200
Microb Biotechnol. 2016 Jul;9(4):486-95
pubmed: 27305897
Microorganisms. 2020 Jul 18;8(7):
pubmed: 32708445
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Front Vet Sci. 2017 Jan 16;3:120
pubmed: 28138438
Vaccine. 2018 Mar 7;36(11):1500-1508
pubmed: 29336925
Vaccine. 2015 Jan 1;33(1):156-62
pubmed: 25444804
Vet Microbiol. 2013 Feb 22;162(1):265-9
pubmed: 22939985
Front Vet Sci. 2018 Sep 19;5:220
pubmed: 30283792
Vaccine. 2019 Apr 3;37(15):2149-2157
pubmed: 30867100
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Food Microbiol. 2013 Oct;36(1):22-9
pubmed: 23764216
J Anim Sci. 2019 Sep 3;97(9):3741-3757
pubmed: 31250899
Vet Microbiol. 2010 Dec 15;146(3-4):361-5
pubmed: 20605375
Curr Opin Gastroenterol. 2014 May;30(3):332-8
pubmed: 24625896
Ecol Lett. 2013 Aug;16(8):951-63
pubmed: 23809147
Vet Microbiol. 2003 Feb 2;91(2-3):135-45
pubmed: 12458163
Front Microbiol. 2018 Jan 26;9:48
pubmed: 29472900
Sci Rep. 2018 Feb 12;8(1):2857
pubmed: 29434295
Infect Immun. 1993 Oct;61(10):4286-92
pubmed: 8406817
Appl Microbiol Biotechnol. 2017 Jul;101(14):5903-5911
pubmed: 28523395
PLoS Comput Biol. 2017 Feb 21;13(2):e1005404
pubmed: 28222096
Vet Res. 2019 Oct 22;50(1):85
pubmed: 31640784
J Comp Pathol. 2011 Aug-Oct;145(2-3):261-70
pubmed: 21334002
mSystems. 2017 May 23;2(3):
pubmed: 28567446
Entropy (Basel). 2019 May 11;21(5):
pubmed: 33267199
Gut Microbes. 2020 Nov 1;11(6):1824-1832
pubmed: 32584645
Microbiologyopen. 2019 Dec;8(12):e923
pubmed: 31496126
PLoS One. 2015 Oct 13;10(10):e0139106
pubmed: 26461107
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Vet Rec. 1977 May 28;100(22):473
pubmed: 301679